A new brain-imaging study has revealed how ketamine produces its fast antidepressant effects in people with treatment-resistant depression.
Researchers tracked changes in a critical brain receptor that helps neurons communicate and found that ketamine reshapes its activity in specific brain regions tied to mood and reward.
These shifts strongly matched improvements in patients’ symptoms. The findings could help scientists develop better ways to predict who will benefit from ketamine therapy.
Read more
Filmmaker Courtney Stephens discusses her documentary on the controversial scientist John C. Lilly.
Lilly was an American scientist who invented the sensory deprivation tank, studied cetacean communication, and experimented with LSD and ketamine—sometimes all at the same time.
Read more
The U.S. Ketamine Clinic industry is growing fast.
This is because more people are looking for new ways to treat mental health problems. It’s already a $3.1B industry, but it’s expected to more than double over the next five years.
Read more
This ketamine trial for resistant depression shows positive results.
The study is the largest to date comparing generic ketamine with placebo in treating severe depression.
Read more